Palavras-chave
cáncer
miopatía
Como Citar
Resumo
La dermatomiositis es una miopatía inflamatoria con afectación cutánea que se ha encontrado asociada con procesos neoplásicos. El artículo presenta el caso de una paciente de 74 años de edad, quien posterior al diagnóstico de dermatomiositis consultó por síntomas de disfagia, asociada con una significativa pérdida de peso. Dadas descripciones previas de la relación de dermatomiositis con cáncer, se decidió iniciar búsqueda de malignidad asociada y se encontró un proceso neoplásico avanzado, con causa primaria desconocida, que requirió manejo paliativo. Por la mayor incidencia de malignidad en pacientes con dermatomiositis, comparada con la población general, es de vital importancia atender a los signos descritos como predictores de la asociación y no pensar en estas como entidades aisladas.
Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am. 2002; 28: 723-41.
Dankó K, Ponyi A, Molnar A, András C, Constantin T. Paraneoplastic myopathy. Curr Opin Rheumatol. 2009;21:594-8.
Suber TL, Casciola-Rosen L, Rosen A. Mechanisms of disease: Autoantigens as clues to the pathogenesis of myositis. Nat Clin Pract Rheumatol. 2008;4:201-9.
Hill CL, Zhang Y, Sigurgeirsson B et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001; 357:96-100.
Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003; 362(9388):971.
Sigurgeirsson B, Lindelôf B, Edhag O et al. Risk of cancer in patients with dermatomyositis o polymyositis. N Engl J Med. 1992;326:363-7.
Baer A. Paraneoplastic muscle disease. Rheum Dis Clin N Am. 2011;37:185-200.
Zampieri S, Valente M, Adami N et al. Polymyositis, dermatomyositis and malignancy: A further intriguing link. Autoimmunity Reviews. 2010;9:449-53.
Levin S. Cancer and myositis: new insights into an old association. Curr Opin Rheumatol. 2006;18:620-4.
Dalakas M. The molecular and celular pathology of inflammatory muscle diseases. Curr Opin Pharmacol. 2001;1: 300-6.
Kohei A, Hidehiro Y, Michiko O et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathicdermatomyositis. Mod Rheumatol. 2011;21:178-83.
Chen Y, Wu C-Y, Shen L. Predicting factors of malignancy in dermatomyositis and polymyositis: a case - control study. Br J Dermatol. 2001;144: 825-31. 13. Sparsa A, Liozon E, Herrmann F et al.
Routine vs extensive malignancy ser for adult dermatomyositis and polymyositis. Arch Dermatol. 2002;138:885-90.
Drake L, Dinehart S, Farmer E et al. Guidelines of care for dermatomyositis. J Am Acad Dermatol. 1996;34(5 Pt 1):824.
Callen JP, Hyla JF, Bole GG Jr, Key DR. The relationship of dermatomyositis and polymyositis to internal malignancy. Arch Dermatol. 1980;116:295-8.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.